Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

GTXI:US

0.7230 USD 0.0170 2.30%

As of 20:10:00 ET on 04/17/2015.

Company Profile for GTx Inc (GTXI)

GTx, Inc. discovers, develops, and commercializes therapeutics primarily related to the treatment of serious men's health conditions. The Company's drug discover and development programs are focused on small molecules that selectively modulate the effects of estrogens and androgens, two essential classes of hormones. GTx is currently developing products for prostate cancer.

Contact Information

GTx Inc

175 Toyota Plaza
7th Floor
Memphis, TN 38103
United States
Phone: 1-901-523-9700
Fax: 1-901-644-8075

Key Executives for GTx Inc (GTXI)

Robert J Wills "Rob"ChairmanMarc S HanoverPresident/CEO/COO/Co-Founder
Henry P DoggrellVP/Chief Legal Officer/SecyJeffrey G HesselbergVP:Regulatory Affairs
Mary Ann JohnstonVP:Medical AffairsJason T ShackelfordSenior Dir:Acctg/Controller

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil